Clinical Trial Update: Neurotransmitter Levels in Children With Specific Learning Disorder [NA]

View source ↗

Summary

A completed clinical trial examined neurotransmitter levels in children with Specific learning disability and in healthy controls.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Specific Learning Disability

Snippet

Sponsor: Dilara Ulger Ozbek | Conditions: Specific Learning Disability, Healthy (Controls) | NA | Status: COMPLETED